Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration: A Systematic Review and Model‐Based Meta‐Analysis-Reference-Cited by-同舟云学术

Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration: A Systematic Review and Model‐Based Meta‐Analysis

Published:2022-01-05 Issue: Volume: Page:
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Luu Kenneth T.¹,Seal Jennifer¹,Green Michelle²,Winskill Carolyn³,Attar Mayssa¹

Affiliation:

1. AbbVie Irvine California USA

2. qPharmetra LLC San Francisco California USA

3. Certara USA Menlo Park California USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.2002

Reference60 articles.

1. Causes and prevalence of visual impairment among adults in the United States;Congdon N;Arch Ophthalmol,2004

3. neovascular age‐related macular degeneration: natural history and treatment outcomes;Pauleikhoff D;Retina,2005

4. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti‐ and pro‐angiogenic therapies;Shibuya M;Genes Cancer,2011

5. Guidelines for the management of neovascular age‐related macular degeneration by the European Society of Retina Specialists (EURETINA);Schmidt‐Erfurth U;Br J Ophthalmol,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Brolucizumab for neovascular age-related macular degeneration: a systematic review and meta-analysis;PeerJ;2024-06-21

2. Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational Study;Clinical Ophthalmology;2024-06

3. Changes in the uninjected contralateral eye after intravitreal brolucizumab for exudative age-related macular degeneration;European Journal of Ophthalmology;2023-07-09

4. The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis;JMIR Research Protocols;2023-06-09

5. Polymeric biomaterials in the treatment of posterior segment diseases;Frontiers in Medicine;2022-08-18